J Korean Diabetes.  2017 Dec;18(4):248-252. 10.4093/jkd.2017.18.4.248.

Diabetes Mellitus and Osteoporosis

• Jin HY

• KMID: 2411423
• DOI: http://doi.org/10.4093/jkd.2017.18.4.248

Abstract

Diabetes mellitus, which is a well-known chronic metabolic disorder with diverse complications, affects over 10% and up to nearly 20% of older adults; its prevalence is increasing rapidly. Fracture is also important issue in a large proportion of older adults and osteoporosis is a common cause of fracture. Therefore, both diabetes and increased fracture risks due to osteoporosis have become serious concerns and health problems in aging societies these days. However, the mechanisms of and exact relationship between diabetes and bone conditions are not fully understood and remain controversial issues because observational and animal studies do not show consistent results. Nonetheless, we should not overlook that bone quality and fractures are also important in older diabetic patients just as in the non-diabetic general population. Therefore, we need a better understanding of how diabetes and its treatment relate to bone health; this will improve morbidity and mortality in older diabetic and osteoporosis patients. Until these questions are answered, we should continue treating diabetic patients for osteoporosis with well-known current medications to improve bone mineral density besides including optimal glucose control and management of micro and macro vascular complications.

Keyword

Bone and bones; Diabetes; Osteoporosis

MeSH Terms

Adult
Aging
Animals
Bone and Bones
Bone Density
Diabetes Mellitus*
Glucose
Humans
Mortality
Osteoporosis*
Prevalence
Glucose

Reference

1. Lieberman D, Fried V, Castel H, Weitzmann S, Lowenthal MN, Galinsky D. Factors related to successful rehabilitation after hip fracture: a case-control study. Disabil Rehabil. 1996; 18:224–230.

2. Dubey A, Aharonoff GB, Zuckerman JD, Koval KJ. The effects of diabetes on outcome after hip fracture. Bull Hosp Jt Dis. 2000; 59:94–98.

3. Loder RT. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res. 1988; (232):210–216.

4. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994; 4:368–381.

5. Leidig-Bruckner G, Ziegler R. Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes. 2001; 109:Suppl 2. S493–S514.

6. Isidro ML, Ruano B. Bone disease in diabetes. Curr Diabetes Rev. 2010; 6:144–155.

7. Kim SH, Kim YM, Yoo JS, Choe EY, Kim TH, Won YJ. Increased risk of hip fractures in Korean patients with type 2 diabetes: a 6-year nationwide population-based study. J Bone Miner Metab. 2016; DOI: 10.1007/s00774-016-0798-z. [Epub ahead of print].

8. Nicodemus KK, Folsom AR. Iowa Women's Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001; 24:1192–1197.

9. Melchior TM, Sørensen H, Torp-Pedersen C. Hip and distal arm fracture rates in peri- and postmenopausal insulin-treated diabet ic females. J Intern Med. 1994; 236:203–208.

10. Paul RG, Bailey AJ. Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol. 1996; 28:1297–1310.

11. Raskin P, Stevenson MR, Barilla DE, Pak CY. The hypercalciuria of diabetes mellitus: its amelioration with insulin. Clin Endocrinol (Oxf). 1978; 9:329–335.

12. Dills DG, Allen C, Palta M, Zaccaro DJ, Klein R, D'Alessio D. Insulin-like growth factor-I is related to glycemic control in children and adolescents with newly diagnosed insulin-dependent diabetes. J Clin Endocrinol Metab. 1995; 80:2139–2143.

13. Jehle PM, Jehle DR, Mohan S, Böhm BO. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. J Endocrinol. 1998; 159:297–306.

14. Wientroub S, Eisenberg D, Tardiman R, Weissman SL, Salama R. Is diabetic osteoporosis due to microangiopathy? Lancet. 1980; 2:983.

15. Vogt MT, Cauley JA, Kuller LH, Nevitt MC. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J Bone Miner Res. 1997; 12:283–289.

16. Iki M, Fujita Y, Kouda K, Yura A, Tachiki T, Tamaki J, Winzenrieth R, Sato Y, Moon JS, Okamoto N, Kurumatani N. Hyperglycemia is associated with increased bone mineral density and decreased trabecular bone score in elderly Japanese men: The Fujiwara-kyo osteoporosis risk in men (FORMEN) study. Bone. 2017; 105:18–25.

17. Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP. Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone. 2001; 28:195–201.

18. Arakaki H, Owan I, Kudoh H, Horizono H, Arakaki K, Ikema Y, Shinjo H, Hayashi K, Kanaya F. Epidemiology of hip fractures in Okinawa, Japan. J Bone Miner Metab. 2011; 29:309–314.

19. Dimai HP, Domej W, Leb G, Lau KH. Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia. J Bone Miner Res. 2001; 16:2132–2141.

20. Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, Donohoe M, Foster AV, Edmonds ME, Boulton AJ. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001; 44:2032–2037.